Quant Healthcare Fund Datagrid
Category Pharma Fund
BMSMONEY Rank N/A
Rating N/A
Growth Option 19-10-2026
NAV ₹17.01(R) -1.21% ₹17.94(D) -1.19%
Returns 1Y 3Y 5Y 7Y 10Y
Lumpsum Regular 9.72% 16.58% -% -% -%
Direct 11.5% 18.5% -% -% -%
Benchmark
SIP (XIRR) Regular 13.96% 9.32% -% -% -%
Direct 15.85% 11.12% -% -% -%
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
Fund AUM As on: 30/12/2025 379 Cr
Top Pharma Fund
Fund Name Rank Rating
SBI Healthcare Opportunities Fund -
UTI Healthcare Fund -
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund -
DSP Healthcare Fund -
Aditya Birla Sun Life Pharma & Healthcare Fund -
Mirae Asset Healthcare Fund -
Nippon India Pharma Fund -
Tata India Pharma & Healthcare Fund -

NAV Date: 19-10-2026

Scheme Name NAV Rupee Change Percent Change
quant Healthcare Fund - Growth Option - Regular Plan 17.01
-0.2100
-1.2100%
quant Healthcare Fund - IDCW Option - Regular Plan 17.01
-0.2100
-1.2100%
quant Healthcare Fund - Growth Option - Direct Plan 17.94
-0.2200
-1.1900%
quant Healthcare Fund - IDCW Option - Direct Plan 17.94
-0.2200
-1.1900%

Review Date: 19-10-2026

Investors beware: Mutual Fund investments are subject to market risks. Please read the scheme related documents carefully.

Data Source: www.amfiindia.com

SEBI Categorization


KPIs* Fund Benchmark Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % -7.90 -5.20
-7.97
-8.83 | -6.35 7 | 17 Good
3M Return % -1.39 -1.40
-4.40
-7.14 | -1.39 1 | 17 Very Good
6M Return % 11.60 14.47
10.92
5.22 | 17.28 8 | 17 Good
1Y Return % 9.72 14.83
7.87
-0.52 | 16.24 7 | 16 Good
3Y Return % 16.58 19.60
18.52
14.89 | 26.33 9 | 11 Average
1Y SIP Return % 13.96
7.11
-19.70 | 20.51 3 | 16 Very Good
3Y SIP Return % 9.32
9.46
-1.46 | 18.93 6 | 11 Good
Return data last Updated On : Oct. 19, 2026.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : June 30, 2026
KPIs: Key Performance Indicators

Rotate the phone! Best viewed in landscape mode on mobile.
KPIs* Fund Benchmark Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % -7.78 -5.20 -7.88 -8.73 | -6.29 7 | 17 Good
3M Return % -0.99 -1.40 -4.09 -6.82 | -0.99 1 | 17 Very Good
6M Return % 12.52 14.47 11.66 5.95 | 18.20 8 | 17 Good
1Y Return % 11.50 14.83 9.33 0.89 | 17.55 7 | 16 Good
3Y Return % 18.50 19.60 19.97 15.92 | 27.83 8 | 11 Average
1Y SIP Return % 15.85 8.60 -18.57 | 22.44 3 | 15 Very Good
3Y SIP Return % 11.12 10.80 -0.05 | 20.35 5 | 10 Good
Return data last Updated On : Oct. 19, 2026.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : June 30, 2026
KPIs: Key Performance Indicators

Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.


Date Quant Healthcare Fund NAV Regular Growth Quant Healthcare Fund NAV Direct Growth
19-10-2026 17.009 17.9383
16-10-2026 17.2168 18.1549
15-10-2026 17.3281 18.2715
14-10-2026 17.3999 18.3464
13-10-2026 17.5598 18.5141
12-10-2026 17.4954 18.4455
09-10-2026 17.4363 18.3807
08-10-2026 17.2791 18.2141
07-10-2026 17.6925 18.6491
06-10-2026 17.8394 18.8031
05-10-2026 17.6436 18.5959
01-10-2026 17.7372 18.6912
30-09-2026 17.8982 18.8601
29-09-2026 18.192 19.1687
28-09-2026 18.2166 19.1938
25-09-2026 18.3263 19.3068
24-09-2026 18.3974 19.3809
23-09-2026 18.505 19.4933
22-09-2026 18.3532 19.3326
21-09-2026 18.468 19.4526

Fund Launch Date: 17/Jul/2023
Fund Category: Pharma Fund
Investment Objective: The primary investment objective of the scheme is to provide capital appreciation by investing in equity and equity related instruments including derivatives and debt and money market instruments. However, there can be no assurance that the investment objective of the Scheme will be realized, as actual market movements may be at variance with anticipated trends.
Fund Description: The primary investment objective of the scheme is to provide capital appreciation by investing in equity and equity related instruments including derivatives and debt and money market instruments. However, there can be no assurance that the investment objective of the Scheme will be realized, as actual market movements may be at variance with anticipated trends.
Fund Benchmark: BSE Healthcare TRI
Source: Fund FactSheet

Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.